Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
1.540
+0.060 (4.05%)
At close: Aug 28, 2025, 4:00 PM
1.500
-0.040 (-2.59%)
After-hours: Aug 28, 2025, 7:56 PM EDT
Trinity Biotech Market Cap
Trinity Biotech has a market cap or net worth of $5.72 million as of August 28, 2025. Its market cap has increased by 22.79% in one year.
Market Cap
5.72M
Enterprise Value
101.32M
1-Year Change
22.79%
Ranking
Category
Stock Price
$1.54
Market Cap Chart
Since October 9, 1997, Trinity Biotech's market cap has decreased from $8.96M to $5.72M, a decrease of -36.21%. That is a compound annual growth rate of -1.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 5.72M | 86.41% |
| Dec 31, 2024 | 3.07M | -6.42% |
| Dec 29, 2023 | 3.28M | -56.55% |
| Dec 30, 2022 | 7.55M | 26.22% |
| Dec 31, 2021 | 5.98M | -62.47% |
| Dec 31, 2020 | 15.93M | 268.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.76B |
| Johnson & Johnson | 425.05B |
| AbbVie | 368.08B |
| UnitedHealth Group | 272.09B |
| AstraZeneca | 248.21B |
| Novartis AG | 243.97B |
| Novo Nordisk | 243.46B |
| Abbott Laboratories | 229.03B |